5. References
1.Gasparotti R,
Pinelli L,
Liserre R.
Insights Imaging (2011) 2:335-347.
New MR sequences in daily practice: susceptibility weigthed omaging.
A pictorial essay.
2.Thomas B,
Somasundaram S,
Thamburaj K,
Kesavadas C,
Gupta Ak et al. Neuroradiology (2008) 50:105-116.
Clinical applications of susceptibility weighted MR imaging of the brain.
A pictorial review.
3.Ong BC,
Stuckey SL.
Journal of Medical Imaging and Radiation Oncology 54 (2010)435-449.
Susceptibility weighted imaging: a pictorial review.
4.Sehgal V,
Delproposto Z,
Haacke EM,
Tong KA,
Wycliffe N et al.
Journal of Magnetic Resonance Imaging 22: 439-450 (2005).
Clinical Applications of Neuroimaging with Susceptibility weighted imaging.
5.Robinson RJ,
Bhuta S.
J NeuroImaging 2011; 21:e189-e204.
Susceptibility weighted imaging of the brain: current utility and potential applications.
6.Tsui YK,
Tsai FY,
Hasso AN,
Greensite F,
Nguyen BV. Journal of Neurological Science 287 (2009)7-16.
Susceptibility weighted imaging for differential diagnosis of cerebral vascular pathology: a pictorial review.
7.Vertinsky AT,
Coenen VA,
Lang DJ,
Kolind S et al.
Localization of the subthalamic nucleus: optimization withSusceptibility-weighted phase MR imaging.
AJNR Am J Neuroradiol.
2009Oct; 30(9):1717-24
8.Haacke EM,
Mittal S,
Wu Z,
Neelavalli J,
Cheng YC (2009) Susceptibility-weighted imaging: technical aspects and clinical applications,
part 1.
AJNR Am J Neuroradiol 30:19–30 2.
9.Reichenbach JR,
Venkatesan R,
Schillinger DJ,
Kido DK,
Haacke EM (1997) Small vessels in the human brain: MR venography with deoxyhemoglobin as an intrinsic contrast agent.
Radiology 204:272–277 3.
10.Reichenbach JR,
Essig M,
Haacke EM et al (1998) Highresolution venography of the brain using magnetic resonance imaging.
Magma 6:62–69 4.
Lee BC,
Vo KD,
Kido DK et al (1999) MR high-resolution blood oxygenation level-dependent venography of occult (low-flow) vascular lesions.
AJNR Am J Neuroradiol 20:1239–1242 5.
11.Barnes SR,
Haacke EM (2009) Susceptibility-weighted imaging: clinical angiographic applications.
Magn Reson Imaging Clin N Am 17:47–61 6.
Pinker K,
Noebauer-Huhmann IM,
Stavrou I et al (2007) Highresolution contrast-enhanced,
susceptibility-weighted MR imaging at 3 T in patients with brain tumors: correlation with positronemission tomography and histopathologic findings.
AJNR Am J Neuroradiol 28:1280–1286